Propanc Biopharma (PPCB) Consolidated Net Income (2011 - 2025)
Propanc Biopharma's Consolidated Net Income came in at -$18.86 million for FY2026 (year ended Jun 30, 2026), compared with -$58.92 million in FY2025.
Powered by 
Analysis
Propanc Biopharma (PPCB) Consolidated Net Income (2011 - 2025) Analysis & Trends
Going back to FY2011, Propanc Biopharma's Consolidated Net Income data covers 16 fiscal years.
- The five-year range for annual Consolidated Net Income is -$58.92 million (FY2025) to -$1.82 million (FY2024).
- Per Business Quant, earlier fiscal years put Consolidated Net Income at -$58.92 million in FY2025, -$1.82 million in FY2024, -$2.66 million in FY2023 and -$2.66 million in FY2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.51 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -237.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Propanc Biopharma | 550,617.42 | 550,617.42 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -3.09 Mn |
| Sep 30, 2025 | -4.84 Mn |
| Jun 30, 2025 | -4.07 Mn |
| Mar 31, 2025 | -54.07 Mn |
| Dec 31, 2024 | -430,183.00 |
| Sep 30, 2024 | -354,310.00 |
| Jun 30, 2024 | -358,578.00 |
| Mar 31, 2024 | -526,700.00 |
| Dec 31, 2023 | -584,384.00 |
| Sep 30, 2023 | -350,866.00 |
| Jun 30, 2023 | -748,044.00 |
| Mar 31, 2023 | -809,809.00 |
| Dec 31, 2022 | -485,418.00 |
| Sep 30, 2022 | -617,295.00 |
| Jun 30, 2022 | -904,765.00 |
| Mar 31, 2022 | -462,687.00 |
| Dec 31, 2021 | -799,977.00 |
| Sep 30, 2021 | -490,658.00 |
| Jun 30, 2021 | -779,021.00 |
| Mar 31, 2021 | -417,738.00 |
API Access
Propanc Biopharma Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=PPCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "PPCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=PPCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();